Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

Blood (2010) 116 (21): 2702.

https://doi.org/10.1182/blood.V116.21.2702.2702

Published: 2010

Journal Articles

Clinical Significance of CD69 Expression In Chronic Lymphocytic Leukemia

Giovanni Del Poeta, Maria Ilaria Del Principe, Pietro Bulian, Cristina Simotti, Francesco Buccisano, MD, Fabrizio Luciano, Antonella Zucchetto, Licia Ottaviani, Luca Maurillo, Chiara Sarlo, Annalisa Biagi, Laura Giannì, Alessio Pio Perrotti, Adriano Venditti, Paolo de Fabritiis, Valter Gattei, Sergio Amadori

Blood (2010) 116 (21): 3574.

https://doi.org/10.1182/blood.V116.21.3574.3574

Published: 2010

Journal Articles

Phase II Study of Bortezomib as a Single Agent In Patients with Relapsed/Refractory or De Novo Acute Myeloid Leukemia Unfit for Intensive Therapy

Chiara Sarlo, Maria Giovanna Cefalo, Eleonora Ceresoli, Licia Ottaviani, Selenia Campagna, Concetta Ditto, Luigi Di Caprio, Maria Ilaria Del Principe, Annibale Franchi, Luca Maurillo, MD, Francesco Buccisano, MD, Sergio Amadori, Adriano Venditti, MD

Blood (2010) 116 (21): 4360.

https://doi.org/10.1182/blood.V116.21.4360.4360

Published: 2010

Journal Articles

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

Blood (2010) 116 (13): 2295–2303.

https://doi.org/10.1182/blood-2009-12-258178

Published: 2010

Includes: Supplemental data

Journal Articles

The Earliest Activation Marker CD69 Is An Independent and Strong Progression Indicator in B-Cell Chronic Lymphocytic Leukemia.

Giovanni Del Poeta, Maria Ilaria Del Principe, Cristina Simotti, Francesco Buccisano, Luca Maurillo, Antonella Zucchetto, Licia Ottaviani, Pietro Bulian, Chiara Sarlo, Maria Irno Consalvo, Adriano Venditti, Paolo de Fabritiis, Valter Gattei, Sergio Amadori

Blood (2009) 114 (22): 2359.

https://doi.org/10.1182/blood.V114.22.2359.2359

Published: 2009

Journal Articles

Rituximab Maintenance Following Chemoimmunotherapy Improves Outcome in B-Cell Chronic Lymphocytic Leukemia.

Giovanni Del Poeta, Maria Ilaria Del Principe, Dario Ragusa, Luca Maurillo, Francesco Buccisano, Licia Ottaviani, Laura Giannì, Fabrizio Luciano, Pietro Bulian, Francesca Maria Rossi, Adriano Venditti, Paolo de Fabritiis, Valter Gattei, Sergio Amadori

Blood (2009) 114 (22): 2364.

https://doi.org/10.1182/blood.V114.22.2364.2364

Published: 2009

Journal Articles

Decisional Algorithm to Incorporate Hematopoietic Stem Cell Transplantation in the Management of Adult Patients with Acute Myeloid Leukaemia.

Francesco Buccisano, M.D., Luca Maurillo, Maria Ilaria Del Principe, Giovanni Del Poeta, Paola Panetta, Emanuele Ammatuna, Licia Ottaviani, Chiara Sarlo, Micol Quaresima, Gottardo De Angelis, Manuela Rizzo, Selenia Campagna, Francesco Lo Coco, William Arcese, Sergio Amadori, Adriano Venditti

Blood (2008) 112 (11): 1519.

https://doi.org/10.1182/blood.V112.11.1519.1519

Published: 2008

Journal Articles

The Amount of Mitochondrial Apoptosis Exerts Prognostic Impact on Normal Karyotype Acute Myeloid Leukemia.

Giovanni Del Poeta, Maria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, Benedetta Neri, Licia Ottaviani, Fabrizio Luciano, Daniela Piccioni, Maria Irno Consalvo, Emanuele Ammatuna, Antonio Bruno, Paolo de Fabritiis, Valter Gattei, Adriano Venditti, Francesco Lo Coco, Sergio Amadori

Blood (2008) 112 (11): 1481.

https://doi.org/10.1182/blood.V112.11.1481.1481

Published: 2008

Journal Articles

Flow-Cytometric Minimal Residual Disease Determination Is a Surrogate Prognosticator in Adult AML Patients Lacking Specific Molecular Signatures.

Francesco Buccisano, MD, Luca Maurillo, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Daniela Fraboni, PhD, Emanuele Ammatuna, MD, Maria Irno Consalvo, PhD, Paola Panetta, PhD, Licia Ottaviani, MD, Sabrina Faccia, MD, Manuela Rizzo, MD, Massimiliano Postorino, MD, Maria Cantonetti, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2007) 110 (11): 3498.

https://doi.org/10.1182/blood.V110.11.3498.3498

Published: 2007

Journal Articles

Optimal Post-Remission Therapy for Flow-Cytometry Minimal Residual Disease Positive Patients with Acute Myeloid Leukemia.

Francesco Buccisano, MD, Luca Maurillo, MD, Valter Gattei, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Fraboni Fraboni, Phd, Paola Panetta, Phd, Maria Irno Consalvo, Phd, Selenia Campagna, MD, Laura Giannì, MD, Licia Ottaviani, MD, Massimiliano Postorino, MD, Paolo De Fabritiis, MD, William Arcese, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2006) 108 (11): 610.

https://doi.org/10.1182/blood.V108.11.610.610

Published: 2006

Journal Articles

Statistical Validation of a Threshold To Discriminate Flow-Cytometry Minimal Residual Disease (MRD) Levels with Prognostic Significance in Acute Myeloid Leukemia (AML).

Francesco Buccisano, MD, Luca Maurillo, MD, Valter Gattei, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Paola Panetta, Phd, Daniela Fraboni, Phd, Maria Irno Consalvo, Phd, Licia Ottaviani, MD, Daniela Renzi, MD, Sabrina Faccia, MD, Chiara Sarlo, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2006) 108 (11): 2299.

https://doi.org/10.1182/blood.V108.11.2299.2299

Published: 2006

Journal Articles

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

Blood (2006) 108 (3): 853–861.

https://doi.org/10.1182/blood-2005-12-4986

Published: 2006

Journal Articles

Monitoring of Minimal Residual Disease (MRD) in Acute Myeloid Leukemia Using Peripheral Blood (PB) as an Alternative Source to Bone Marrow (BM).

Luca Maurillo, MD, Francesco Buccisano, MD, Benedetta Neri, MD, Carla Mazzone, MD, Giovanni Del Poeta, MD, Licia Ottaviani, MD, Pasquale Niscola, MD, Ilaria Del Principe, MD, Anna Tamburini, MD, Maria Irno Consalvo, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2005) 106 (11): 2361.

https://doi.org/10.1182/blood.V106.11.2361.2361

Published: 2005

Journal Articles

The Kinetic of Reduction of Minimal Residual Disease Impacts on duration of Response snd Survival of Patients with Acute Myeloid Leukemia.

Francesco Buccisano, MD, Luca Maurillo, MD, Giovanni Del Poeta, MD, Anna Tamburini, MD, Maria Christina Cox, MD, Maria Ilaria Del Principe, MD, Maria Irno Consalvo, PhD, Carla Mazzone, MD, Benedetta Neri, MD, Licia Ottaviani, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2004) 104 (11): 399.

https://doi.org/10.1182/blood.V104.11.399.399

Published: 2004

NARROW

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

Clinical Significance of CD69 Expression In Chronic Lymphocytic Leukemia

Phase II Study of Bortezomib as a Single Agent In Patients with Relapsed/Refractory or De Novo Acute Myeloid Leukemia Unfit for Intensive Therapy

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

The Earliest Activation Marker CD69 Is An Independent and Strong Progression Indicator in B-Cell Chronic Lymphocytic Leukemia.

Rituximab Maintenance Following Chemoimmunotherapy Improves Outcome in B-Cell Chronic Lymphocytic Leukemia.

Decisional Algorithm to Incorporate Hematopoietic Stem Cell Transplantation in the Management of Adult Patients with Acute Myeloid Leukaemia.

The Amount of Mitochondrial Apoptosis Exerts Prognostic Impact on Normal Karyotype Acute Myeloid Leukemia.

Flow-Cytometric Minimal Residual Disease Determination Is a Surrogate Prognosticator in Adult AML Patients Lacking Specific Molecular Signatures.

Optimal Post-Remission Therapy for Flow-Cytometry Minimal Residual Disease Positive Patients with Acute Myeloid Leukemia.

Statistical Validation of a Threshold To Discriminate Flow-Cytometry Minimal Residual Disease (MRD) Levels with Prognostic Significance in Acute Myeloid Leukemia (AML).

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

Monitoring of Minimal Residual Disease (MRD) in Acute Myeloid Leukemia Using Peripheral Blood (PB) as an Alternative Source to Bone Marrow (BM).

The Kinetic of Reduction of Minimal Residual Disease Impacts on duration of Response snd Survival of Patients with Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only